Nevro to Present at UBS Global Healthcare Virtual Conference

Rhea-AI Summary

Nevro Corp. (NYSE: NVRO), a leading medical device company specializing in chronic pain solutions, announced that its Chairman and CEO, D. Keith Grossman, will present at the UBS Global Healthcare Virtual Conference on May 24, 2021, at 4:00 pm ET. The event will be accessible via a live webcast and archived recording on Nevro's website.

Nevro is known for its innovative Senza spinal cord stimulation system, which has shown positive outcomes, including opioid reduction in over 65% of patients in clinical studies. For more information, visit www.nevro.com.

REDWOOD CITY, Calif., April 27, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman, Nevro's Chairman, CEO and President, will present at the UBS Global Healthcare Virtual Conference on Monday, May 24, 2021 at 4:00 pm Eastern Time / 1:00 pm Pacific Time.

A live webcast of this event, as well as an archived recording, will be available in the Investors section of Nevro's website at www.nevro.com. 

Internet Posting of Information

Nevro routinely posts information that may be important to investors in the "Investor Relations" section of its website at www.nevro.com.  The company encourages investors and potential investors to consult the Nevro website regularly for important information about Nevro.

About Nevro

Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based, non-pharmacologic neuromodulation platform for the treatment of chronic pain. HF10 therapy has demonstrated the ability to reduce or eliminate opioids in ≥65% of patients across six peer-reviewed clinical studies. The Senza® System, Senza II™ System, and the Senza® Omnia™ System are the only SCS systems that deliver Nevro's proprietary HF10® therapy. Senza, Senza II, Senza Omnia, HF10, Nevro and the Nevro logo are trademarks of Nevro Corp.

To learn more about Nevro, connect with us on LinkedIn, Twitter, Facebook and Instagram.

Investors and Media:
Julie Dewey, IRC
Nevro Corp.
Vice President, Investor Relations & Corp Communications
650-433-3247  |  julie.dewey@nevro.com 

View original content to download multimedia:http://www.prnewswire.com/news-releases/nevro-to-present-at-ubs-global-healthcare-virtual-conference-301275869.html

SOURCE Nevro Corp.

FAQ

What date is Nevro presenting at the UBS Global Healthcare Virtual Conference?

Nevro will present at the UBS Global Healthcare Virtual Conference on May 24, 2021.

Who will represent Nevro at the UBS Global Healthcare Virtual Conference?

D. Keith Grossman, Nevro's Chairman and CEO, will represent the company.

What time is Nevro's presentation at the conference?

Nevro's presentation is scheduled for 4:00 pm Eastern Time on May 24, 2021.

Where can I watch Nevro's conference presentation?

The presentation can be watched live and will also be archived on Nevro's website.

What is Nevro's stock symbol?

Nevro's stock symbol is NVRO.

What products does Nevro provide for chronic pain treatment?

Nevro offers the Senza spinal cord stimulation system, which includes HF10 therapy, a non-pharmacologic treatment for chronic pain.